Home/Tag: biotech

Lazarus Drugs

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market. By Kate Yandell | February 1, 2015 - The Scientist © AVARAND/SHUTTERSTOCK This past August, the US Food and Drug Administration (FDA) approved an intravenous antibiotic called oritavancin (Orbactiv) to treat skin infections, some 20 years after the pharmaceutical